Search Results

Drugmakers are being increasingly scrutinized by the DOJ, as seen with recent indictments over the opioid crisis.

The FDA previously warned that it would pursue CBD sellers making "egregious, over-the-line claims."

Newly released records from the DEA offer a look at the flow of opioids from manufacturers and distributors to states.

The pharma group recently hired a star lawyer — but will that lead to a fair settlement?

The federal agency set a July 2 deadline for written responses to the issues raised in the hearing.

Oklahoma lawyers want Johnson & Johnson to fund a 20-year opioid abatement program at a cost of $800 million a year up to 20 years. Can you say 'Big Tobacco'?

At issue in the case was whether state-law failure-to-warn suits against Merck were preempted by federal law.

News from Gjensidige Group, Duck Creek Technologies, Next Insurance and more.